Alyeska Investment Group’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-608,604
| Closed | -$402K | – | 718 |
|
|
2024
Q2 | $402K | Sell |
608,604
-17,832
| -3% | -$11.8K | ﹤0.01% | 470 |
|
|
2024
Q1 | $377K | Hold |
626,436
| – | – | ﹤0.01% | 413 |
|
|
2023
Q4 | $368K | Sell |
626,436
-70,300
| -10% | -$41.3K | ﹤0.01% | 402 |
|
|
2023
Q3 | $464K | Buy |
+696,736
| New | +$464K | ﹤0.01% | 434 |
|
|
2020
Q3 | – | Sell |
-7,333
| Closed | -$682K | – | 606 |
|
|
2020
Q2 | $682K | Buy |
+7,333
| New | +$682K | 0.01% | 402 |
|
|
2019
Q4 | – | Sell |
-52,787
| Closed | -$746K | – | 477 |
|
|
2019
Q3 | $746K | Buy |
+52,787
| New | +$746K | 0.01% | 312 |
|